CCM
ANGO icon

Coldstream Capital Management’s AngioDynamics ANGO Stock Holding History

Coldstream Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Buy
+11,475
New +$131K ﹤0.01% 1190
2025
Q2 		– Sell
-8,161
Closed -$76.6K – 1228
2025
Q1 		$76.6K Buy
+8,161
New +$85.8K ﹤0.01% 1488

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Coldstream Capital Management's ANGO Position: Q2 2026 in Review

Coldstream Capital Management opened a new position in AngioDynamics (ANGO) in Q2 2026: 11,475 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #1190 among its holdings. This is a return to the name: Coldstream Capital Management previously reported a position in ANGO as recently as Q1 2025.

Coldstream Capital Management first reported a position in ANGO in Q1 2025 and has held it in 2 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Coldstream Capital Management held 11,475 shares of AngioDynamics worth $149K as of Q2 2026.
  • AngioDynamics was a new Coldstream Capital Management position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1190 holding.
  • Coldstream Capital Management first reported a position in AngioDynamics in Q1 2025 and has held it in 2 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.